chr2-190880872-CGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_014905.5(GLS):c.-194_-165del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 742,982 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0023 ( 1 hom., cov: 0)
Exomes 𝑓: 0.00095 ( 4 hom. )
Consequence
GLS
NM_014905.5 5_prime_UTR
NM_014905.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.335
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 2-190880872-CGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-C is Benign according to our data. Variant chr2-190880872-CGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-C is described in ClinVar as [Likely_benign]. Clinvar id is 3031213.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00234 (350/149612) while in subpopulation AFR AF= 0.00287 (117/40702). AF 95% confidence interval is 0.00245. There are 1 homozygotes in gnomad4. There are 179 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLS | NM_014905.5 | c.-194_-165del | 5_prime_UTR_variant | 1/18 | ENST00000320717.8 | ||
LOC124906110 | XR_007087791.1 | n.743_772del | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLS | ENST00000320717.8 | c.-194_-165del | 5_prime_UTR_variant | 1/18 | 1 | NM_014905.5 | P1 | ||
GLS | ENST00000338435.9 | c.-194_-165del | 5_prime_UTR_variant | 1/15 | 1 | ||||
ENST00000413911.1 | n.814_843del | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
GLS | ENST00000479552.1 | n.20_49del | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00234 AC: 350AN: 149512Hom.: 1 Cov.: 0
GnomAD3 genomes
AF:
AC:
350
AN:
149512
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000954 AC: 566AN: 593370Hom.: 4 AF XY: 0.000854 AC XY: 270AN XY: 316170
GnomAD4 exome
AF:
AC:
566
AN:
593370
Hom.:
AF XY:
AC XY:
270
AN XY:
316170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00234 AC: 350AN: 149612Hom.: 1 Cov.: 0 AF XY: 0.00245 AC XY: 179AN XY: 72928
GnomAD4 genome
AF:
AC:
350
AN:
149612
Hom.:
Cov.:
0
AF XY:
AC XY:
179
AN XY:
72928
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GLS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at